AngioDynamics (ANGO) Tops Q2 EPS by 4c, Revenues Miss; Offers FY20 EPS/Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. DASH
8. SYK
9. GILD
10. SBUX

Go back to AngioDynamics (ANGO) Tops Q2 EPS by 4c, Revenues Miss; Offers FY20 EPS/Revenue Outlook

AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results

January 7, 2020 7:00 AM EST

Fiscal 2020 Second Quarter Highlights

Net sales of $70.0 million, flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07; adjusted earnings per share of $0.06 Announces the acquisition of C3 Wave PICC tip location system subsequent to quarter end

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc.(NASDAQ: ANGO),a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and... More